The Centers for Medicare & Medicaid Services is changing how states select candidates for the Special Focus Facility Program to put more emphasis on fall rates as a reflection of quality, the agency ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...

Days after revealing them, regulators withdrew new coverage determinations for skin substitutes used to treat diabetic foot and venous leg ulcers.

Medicare will negotiate prices for Part B injectable drugs for the first time, aiming to lower costs for millions of patients ...

The American Telemedicine Association, or ATA, urged Congress to quickly act to avoid the expiration of key telehealth services on Jan. 30, which are being threatened by an “unrelated partisan debate.

Earlier this week, the Centers for Medicare & Medicaid Services (CMS) released the Contract Year (CY) 2027 Medicare Advantage (MA) and Part D ...

The Department of Health and Human Services Office of Inspector General yesterday released a bulletin addressing how direct-to-consumer drug programs can sell prescription drugs to patients with ...

The Centers for Medicare & Medicaid Services yesterday announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations. Negotiations will occur this year and any ...

Medicare selected Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.

Over the past week, health insurers have drawn the ire of lawmakers on both sides of the aisle and seen their collective stock prices drop by nearly $100 billion following unfavorable Medicare ...

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...